These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3585746)

  • 21. A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate.
    Bertino JS; Nafziger AN; Rotschafer JC
    Am J Med; 1999 Sep; 107(3):296-8. PubMed ID: 10492331
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
    Verghese A; Berk SL
    Am J Med; 1983 Jun; 74(6):1092. PubMed ID: 6222648
    [No Abstract]   [Full Text] [Related]  

  • 24. Ticarcillin: pharmacokinetics in man according to different administration schedules.
    Dalhoff A; Höffler D
    J Int Med Res; 1977; 5(5):308-21. PubMed ID: 913858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
    Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH
    Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
    de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
    Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ticarcillin in the dog.
    Tilmant L; Brown MP; Gronwall RR
    Am J Vet Res; 1985 Feb; 46(2):479-81. PubMed ID: 3922261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
    Choi C; Bayer AS; Fujita NK; Lam K; Guze LB; Yoshikawa TT
    Chemotherapy; 1983; 29(4):303-12. PubMed ID: 6872621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy between amikacin and ticarcillin or mezlocillin against nosocomial bloodstream isolates.
    Guenthner SH; Chao HP; Wenzel RP
    J Antimicrob Chemother; 1986 Oct; 18(4):550-2. PubMed ID: 3771436
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin.
    Viollier AF; Standiford HC; Drusano GL; Tatem BA; Moody MR; Schimpff SC
    J Antimicrob Chemother; 1985 May; 15(5):597-606. PubMed ID: 4008387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration to peripheral human lymph of clavulanic acid and ticarcillin.
    Bergan T; Olszewski W; Engeset A
    J Antimicrob Chemother; 1986 Jan; 17(1):97-103. PubMed ID: 3949640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ticarcillin activity in immunodepressed mice infected with "Pseudomonas aeruginosa" (author's transl)].
    Fauchère JL; Simonet M; de Meirleire F; Véron M
    Ann Microbiol (Paris); 1981; 132B(2):215-24. PubMed ID: 6798910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of amikacin in synovial fluid after regional limb perfusion of amikacin sulfate alone and in combination with ticarcillin/clavulanate in horses.
    Zantingh AJ; Schwark WS; Fubini SL; Watts AE
    Vet Surg; 2014 Mar; 43(3):282-8. PubMed ID: 24467593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic comparison of mezlocillin and ticarcillin.
    Deeter RG; Barriere SL; Fekety R
    Clin Pharm; 1988 May; 7(5):380-4. PubMed ID: 3383544
    [No Abstract]   [Full Text] [Related]  

  • 38. Neonatal ticarcillin dosage.
    Nelson JD
    Pediatrics; 1979 Oct; 64(4):549-50. PubMed ID: 492825
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bioavailability of chemotherapeutics in high-volume fluid therapy].
    Dalhoff A; Koeppe P; Hulla F
    Dtsch Med Wochenschr; 1981 Dec; 106(51-52):1754-6. PubMed ID: 7327094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.